Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters

Molecular Nutrition and Food Research

Volumn 55, Issue 7, 2011, Pages 979-988

  Wong, Chi C ^a   Barron, Denis ^b   Orfila, Caroline ^a   Dionisi, Fabiola ^b   Krajcsi, Peter ^c   Williamson, Gary ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c SOLVO BIOTECHNOLOGY   (Hungary)

Author keywords

Bioavailability; Hydroxycinnamic acids; Multidrug resistance transporters; Organic anion transporters

Indexed keywords

4 AMINOHIPPURIC ACID; 4 CARBOXYFLUORESCEIN; 4-CARBOXYFLUORESCEIN; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; COUMARIC ACID; FLUORESCEIN DERIVATIVE; GLUCURONIDE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; SLC22A11 PROTEIN, HUMAN; SLC22A7 PROTEIN, HUMAN; SULFATE; TUMOR PROTEIN;

ARTICLE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; KIDNEY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE; COUMARIC ACIDS; FLUORESCEINS; GLUCURONIDES; HUMANS; KIDNEY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; P-AMINOHIPPURIC ACID; SULFATES;

AVENA;

EID: 79956110490     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000652     Document Type: Article

References (40)

1. Tomas-Barberan, F. A., Clifford, M. N., Dietary hydroxybenzoic acid derivatives - nature, occurrence and dietary burden. J. Sci. Food Agric. 2000, 80, 1024-1032.
2. Natella, F., Nardini, M., Giannetti, I., Dattilo, C., Scaccini, C., Coffee drinking influences plasma antioxidant capacity in humans. J. Agric. Food Chem. 2002, 50, 6211-6216.
3. Natella, F., Nardini, M., Belelli, F., Scaccini, C., Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am. J. Clin. Nutr. 2007, 86, 604-609.
4. Poquet, L., Clifford, M. N., Williamson, G., Effect of dihydrocaffeic acid on UV irradiation of human keratinocyte HaCaT cells. Arch. Biochem. Biophys. 2008, 476, 196-204.
5. Wong, C. C., Meinl, W., Glatt, H. R., Barron, D. et al., In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans. J. Nutr. Biochem. 2010, 21, 1060-1068.
6. Stalmach, A., Mullen, W., Barron, D., Uchida, K. et al., Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab. Dispos. 2009, 37, 1749-1758.
7. Bourne, L., Paganga, G., Baxter, D., Hughes, P., Rice-Evans, C., Absorption of ferulic acid from low-alcohol beer. Free Radic. Res. 2000, 32, 273-280.
8. Rondini, L., Peyrat-Maillard, M. N., Marsset-Baglieri, A., Berset, C., Sulfated ferulic acid is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats. J. Agric. Food Chem. 2002, 50, 3037-3041.
9. Nardini, M., Natella, F., Scaccini, C., Ghiselli, A., Phenolic acids from beer are absorbed and extensively metabolized in humans. J. Nutr. Biochem. 2006, 17, 14-22.
10. Nardini, M., Cirillo, E., Natella, F., Scaccini, C., Absorption of phenolic acids in humans after coffee consumption. J. Agric. Food Chem. 2002, 50, 5735-5741.
11. Kern, S. M., Bennett, R. N., Mellon, F. A., Kroon, P. A., Garcia-Conesa, M. T., Absorption of hydroxycinnamates in humans after high-bran cereal consumption. J. Agric. Food Chem. 2003, 51, 6050-6055.
12. Pestana, M., Faria, M. S., Oliveira, J. G., Baldaia, J. et al., Assessment of renal dopaminergic system activity during the recovery of renal function in human kidney transplant recipients. Nephrol. Dial. Transplant. 1997, 12, 2667-2672.
13. Baines, A. D., Craan, A., Chan, W., Morgunov, N., Tubular secretion and metabolism of dopamine, norepinephrine, methoxytyramine and normetanephrine by the rat kidney. J. Pharmacol. Exp. Ther. 1979, 208, 144-147.
14. Enomoto, A., Takeda, M., Tojo, A., Sekine, T. et al., Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J. Am. Soc. Nephrol. 2002, 13, 1711-1720.
15. Cha, S. H., Sekine, T., Fukushima, J. I., Kanai, Y. et al., Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol. Pharmacol. 2001, 59, 1277-1286.
16. Kojima, R., Sekine, T., Kawachi, M., Cha, S. H. et al., Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J. Am. Soc. Nephrol. 2002, 13, 848-857.
17. VanWert, A. L., Gionfriddo, M. R., Sweet, D. H., Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm. Drug Dispos. 2010, 31, 1-71.
18. Nigam, S. K., Bush, K. T., Bhatnagar, V., Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nat. Clin. Pract. Nephrol. 2007, 3, 443-448.
19. Enomoto, A., Takeda, M., Shimoda, M., Narikawa, S. et al., Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J. Pharmacol. Exp. Ther. 2002, 301, 797-802.
20. Sekine, T., Cha, S. H., Tsuda, M., Apiwattanakul, N. et al., Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 1998, 429, 179-182.
21. Konig, J., Nies, A. T., Cui, Y., Leier, I., Keppler, D., Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta 1999, 1461, 377-394.
22. Williamson, G., Aeberli, I., Miguet, L., Zhang, Z. et al., Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metab. Dispos. 2007, 35, 1262-1268.
23. Hagos, Y., Stein, D., Ugele, B., Burckhardt, G., Bahn, A., Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J. Am. Soc. Nephrol. 2007, 18, 430-439.
24. Fumeaux, R., Menozzi-Smarrito, C., Stalmach, A., Munari, C. et al., First synthesis, characterization, and evidence for the presence of hydroxycinnamic acid sulfate and glucuronide conjugates in human biological fluids as a result of coffee consumption. Org. Biomol. Chem. 2010, 8, 5199-5211.
25. Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., Scarborough, G. A., Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 1992, 267, 4854-4858.
26. Bakos, E., Evers, R., Sinko, E., Varadi, A. et al., Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol. 2000, 57, 760-768.
27. Bodo, A., Bakos, E., Szeri, F., Varadi, A., Sarkadi, B., Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J. Biol. Chem. 2003, 278, 23529-23537.
28. Pal, A., Mehn, D., Molnar, E., Gedey, S. et al., Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2. J. Pharmacol. Exp. Ther. 2007, 321, 1085-1094.
29. Truong, D. M., Kaler, G., Khandelwal, A., Swaan, P. W., Nigam, S. K., Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination. J. Biol. Chem. 2008, 283, 8654-8663.
30. Leslie, E. M., Deeley, R. G., Cole, S. P., Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 2005, 204, 216-237.
31. Wortelboer, H. M., Usta, M., van Zanden, J. J., van Bladeren, P. J. et al., Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha, beta-unsaturated carbonyl compounds. Biochem. Pharmacol. 2005, 69, 1879-1890.
32. Dantzler, W. H., Wright, S. H., Renal tubular secretion of organic anions. Adv. Drug Deliv. Rev. 1997, 25, 217-230.
33. Deguchi, T., Kusuhara, H., Takadate, A., Endou, H. et al., Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int. 2004, 65, 162-174.
34. Mizuno, N., Takahashi, T., Iwase, Y., Kusuhara, H. et al., Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab. Dispos. 2007, 35, 1429-1434.
35. Bakhiya, N., Stephani, M., Bahn, A., Ugele, B. et al., Uptake of chemically reactive, DNA-damaging sulfuric acid esters into renal cells by human organic anion transporters. J. Am. Soc. Nephrol. 2006, 17, 1414-1421.
36. Sekine, T., Miyazaki, H., Endou, H., Molecular physiology of renal organic anion transporters. Am. J. Physiol. Renal. 2006, 290, F251-F261.
37. Ekaratanawong, S., Anzai, N., Jutabha, P., Miyazaki, H. et al., Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J. Pharmacol. Sci. 2004, 94, 297-304.
38. Imaoka, T., Kusuhara, H., Adachi, M., Schuetz, J. D. et al., Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol. Pharmacol. 2007, 71, 619-627.
39. Chao, C. Y., Mong, M. C., Chan, K. C., Yin, M. C., Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol. Nutr. Food Res. 2010, 54, 388-395.
40. Jung, K. J., Go, E. K., Kim, J. Y., Yu, B. P., Chung, H. Y., Suppression of age-related renal changes in NF-kappaB and its target gene expression by dietary ferulate. J. Nutr. Biochem. 2009, 20, 378-388.